correspondent-denominate
Living With Myelofibrosis

research

Myelofibrosis: Now and What’s Coming for Treatment

Dr. Moshe Talpaz, world renowned myeloid disease specialist from the University of Michigan, explains the continuing progress in the treatment of myelofibrosis and the promise of better treatments to come. Dr. Talpaz expresses his excitement for the ongoing research in this challenging and at times frustrating condition. With the discovery… Continue reading

Funding aids potential new therapy for CLL, lymphomas and myeloma

The Leukaemia Foundation is buoyed by recent news reports that an experimental pill, ABT-199, has “dramatically” reduced leukaemia cells in the blood within eight hours of being administered to a patient with chronic lymphocytic leukaemia (CLL) in a Melbourne trial.

The pill, known as ABT-199, is reported to attack the… Continue reading

Myelofibrosis Stem Cells Could Exist In The Spleens Of Sufferers

Myelofibrosis control tissues in the spleens of patients with this disorder might sustain difference programs equivalent to those located in normal hematopoietic control tissues, based on research outcomes.

The researchers carried out the study to establish the effects of innate qualities of and regulating alerts supplied by the microenvironment in… Continue reading

An Expert’s Perspective: The Explosive Research in Myelofibrosis

Things are changing in myelofibrosis. As researchers better understand the genetics of the condition, they are working to develop new drugs to reduce or eliminate side affects of the illness and treat the underlying condition in a patient’s blood cell factory, the bone marrow. A leading scientist and clinician in… Continue reading

The Promise of Better Treatments for Myelofibrosis

The landscape of care is changing for patients with myelofibrosis. A new drug, that experts say can significantly improve symptoms for many patients, has been recently approved while significant research is underway to better manage the progressive scarring in the bone marrow which is at the root of the condition.… Continue reading

The Promise of Better Treatments for Myelofibrosis

The landscape of care is changing for patients with myelofibrosis. A new drug, that experts say can significantly improve symptoms for many patients, has been recently approved while significant research is underway to better manage the progressive scarring in the bone marrow which is at the root of the condition.… Continue reading

Blood Cancer Research Foundation Changes Name

Chicago, IL (PRWEB) April 4, 2011

The MPD Foundation, a patient-led foundation dedicated to the discovery of treatments and a cure for three rare blood cancers (myelofibrosis, polycythemia vera, and essential thrombocythemia) announces today a new name for the organization, which will now be known as the MPN Research Foundation.… Continue reading

MPN Research Foundation and The Leukemia & Lymphoma Society Partner to Spur Innovation in Fibrosis Research

Chicago and White Plains, New York (PRWEB) January 23, 2012

Applicants for this concept grant program (titled the MF Challenge) will have until April 1, 2012 to submit their proposal for funding in the amount of up to $ 100,000 per grant. The grant review will take place in June… Continue reading

Catriona Jamieson – UCSD | CIRM Spotlight on Genomics

This seminar, presented to the California Institute for Regenerative Medicine governing board on January 17th, 2012, provides a glimpse into a future of personalized medicine in which genomics, the study of genes and their function, is applied to pinpoint specific treatments for patients. Speakers include Catriona Jamieson, director for stem… Continue reading

Translate This Page
Who's Online
3 visitors online now
Follow Us

Copyright © 2011. All Rights Reserved.